These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 10722138)
1. The logic of causation and the risk of paralytic poliomyelitis for an American child. Ridgway D Epidemiol Infect; 2000 Feb; 124(1):113-20. PubMed ID: 10722138 [TBL] [Abstract][Full Text] [Related]
2. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708 [TBL] [Abstract][Full Text] [Related]
3. Vaccine policy changes and epidemiology of poliomyelitis in the United States. Alexander LN; Seward JF; Santibanez TA; Pallansch MA; Kew OM; Prevots DR; Strebel PM; Cono J; Wharton M; Orenstein WA; Sutter RW JAMA; 2004 Oct; 292(14):1696-701. PubMed ID: 15479934 [TBL] [Abstract][Full Text] [Related]
4. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). Prevots DR; Burr RK; Sutter RW; Murphy TV; MMWR Recomm Rep; 2000 May; 49(RR-5):1-22; quiz CE1-7. PubMed ID: 15580728 [TBL] [Abstract][Full Text] [Related]
5. [VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)]. Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Gmyl AP; Yakovenko ML; Korotkova EA; Chernjavskaja OP; Baykova OY; Silenova OV; Krasota AY; Krasnoproshina LI; Mustafina AN; Kozlovskaja LI Vopr Virusol; 2016; 61(1):9-15. PubMed ID: 27145594 [TBL] [Abstract][Full Text] [Related]
6. [Polio vaccines, eradication and posterradication]. Salmerón García F; Portela Moreira A; Soler Soneira M; López Hernández S; Chamorro Somoza Díaz-Sarmiento M; Pérez González I; Rubio Gómez MI; Pérez González A; Sagredo Rodríguez A; Ruiz Antúnez S; Timón Jiménez M; Frutos Cabanillas G Rev Esp Salud Publica; 2013; 87(5):497-505. PubMed ID: 24322286 [TBL] [Abstract][Full Text] [Related]
7. Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine-Associated Paralytic Poliomyelitis - Beijing, China, 2014-2016. Zhao D; Ma R; Zhou T; Yang F; Wu J; Sun H; Liu F; Lu L; Li X; Zuo S; Yao W; Yin J MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(49):1357-1361. PubMed ID: 29240729 [TBL] [Abstract][Full Text] [Related]
8. The future of polio immunization in the United States: are we ready for change? Paradiso PR Pediatr Infect Dis J; 1996 Aug; 15(8):645-9. PubMed ID: 8858665 [No Abstract] [Full Text] [Related]
10. Decision analysis in planning for a polio outbreak in the United States. Jenkins PC; Modlin JF Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814 [TBL] [Abstract][Full Text] [Related]
11. New recommendations for poliovirus vaccination. Combination regimen captures best effects of available vaccines. Conrad DA; Jenson HB Postgrad Med; 1997 Nov; 102(5):45-8, 51-3, 59-60 passim. PubMed ID: 9385331 [TBL] [Abstract][Full Text] [Related]
12. Poliomyelitis prevention: revised recommendations for use of inactivated and live oral poliovirus vaccines. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics; 1999 Jan; 103(1):171-2. PubMed ID: 9917460 [TBL] [Abstract][Full Text] [Related]
13. Polio vaccines: WHO position paper – March, 2016. Wkly Epidemiol Rec; 2016 Mar; 91(12):145-68. PubMed ID: 27039410 [No Abstract] [Full Text] [Related]
14. Paralytic poliomyelitis--United States, 1980-1994. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(4):79-83. PubMed ID: 9048844 [TBL] [Abstract][Full Text] [Related]
15. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis. Pliaka V; Kyriakopoulou Z; Markoulatos P Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246 [TBL] [Abstract][Full Text] [Related]
16. The challenge of changing the inactivated poliomyelitis vaccine in Latin America: declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE). Falleiros-Arlant LH; Avila-Agüero ML; Brea del Castillo J; Mariño C Rev Chilena Infectol; 2014 Oct; 31(5):590-603. PubMed ID: 25491459 [TBL] [Abstract][Full Text] [Related]
17. Indian experts favour IPV to eradicate polio. Sharma DC Lancet; 2003 Oct; 362(9392):1292. PubMed ID: 14577440 [No Abstract] [Full Text] [Related]
18. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization. Khan MM; Sharma S; Tripathi B; Alvarez FP Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194 [TBL] [Abstract][Full Text] [Related]
19. World wide experience with inactivated poliovirus vaccine. Bonnet MC; Dutta A Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777 [TBL] [Abstract][Full Text] [Related]
20. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study. O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA; Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]